China Kanghui Holdings to Present at the 29th
Annual J.P. Morgan Healthcare Conference
JPMorgan Healthcare Conference 2011
January 06, 2011 04:08 PM Eastern Time
CHANGZHOU, China--(EON: Enhanced Online News)--China Kanghui Holdings (NYSE: KH) (“Kanghui” or the
“Company”), a leading domestic developer, manufacturer and marketer of orthopedic implants in China, today
announced that the Company will present at the 29th Annual J.P. Morgan Healthcare Conference, to be held
January 10-13, 2011 at the Westin St. Francis Hotel in San Francisco. Management is currently scheduled to
present at 2:30 pm PT on Wednesday, January 12, 2011, and to meet with institutional investors throughout the
duration of the conference. A webcast of the presentation will be available via the investor relations portion of the
Company’s website at http://www.kanghui.com.
For further details, please contact the Company’s investor relations department at 1-646-416-6822, or contact your
J.P. Morgan institutional sales representative.
About China Kanghui Holdings
Founded in 1997, Kanghui is a leading domestic developer, manufacturer and marketer of orthopedic implants in
China. The Company offers a wide array of proprietary orthopedic implant products in trauma and spine. It has an
extensive network of distributors for its products in China. In addition, Kanghui’s products are distributed in 24
countries. Kanghui has strong research and development capabilities, focused on developing new proprietary
products, including new product lines, extensions of existing product lines and enhancements of existing products.
For more information, please visit www.kanghui.com.
Kanghui Investor Relations Department
In the U.S.:
Ashley M. Ammon: 1-646-277-1227
Wen Lei Zheng: 86-10-6583-7510